Scribd Logo
Upload

Welcome to Scribd!

  • Drug Study 12 and 13

    Uploaded by

    JeinIccri
    8 views2 pages
    Ranitidine is an H2 receptor antagonist used to prevent ulcers while a patient is NPO. It works by competitively inhibiting histamine at H2 receptors in the gastric parietal cells, which reduces gastric acid secretion, volume, and hydrogen ion concentration. It is given intravenously at 50mg every 8 hours while the patient is NPO. Nurses should assess for signs of ulceration and monitor for potential side effects like constipation, diarrhea, and headache. Diloxanide furoate is an antiprotozoal drug used to treat intestinal amoebiasis after tissue amoebicides to eradicate cysts. It is given orally at 500mg

    Original Description:

    Original Title

    Drug study 12 and 13 (1).docx

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Ranitidine is an H2 receptor antagonist used to prevent ulcers while a patient is NPO. It works by competitively inhibiting histamine at H2 receptors in the gastric parietal cells, which reduces gastric acid secretion, volume, and hydrogen ion concentration. It is given intravenously at 50mg every 8 hours while the patient is NPO. Nurses should assess for signs of ulceration and monitor for potential side effects like constipation, diarrhea, and headache. Diloxanide furoate is an antiprotozoal drug used to treat intestinal amoebiasis after tissue amoebicides to eradicate cysts. It is given orally at 500mg

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    8 views2 pages

    Drug Study 12 and 13

    Uploaded by

    JeinIccri
    Ranitidine is an H2 receptor antagonist used to prevent ulcers while a patient is NPO. It works by competitively inhibiting histamine at H2 receptors in the gastric parietal cells, which reduces gastric acid secretion, volume, and hydrogen ion concentration. It is given intravenously at 50mg every 8 hours while the patient is NPO. Nurses should assess for signs of ulceration and monitor for potential side effects like constipation, diarrhea, and headache. Diloxanide furoate is an antiprotozoal drug used to treat intestinal amoebiasis after tissue amoebicides to eradicate cysts. It is given orally at 500mg

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 2

    Drugs

    Classification

    Generic:
    Ranitidine

    Gastointestinal
    agents:

    Brand:
    Zantac

    Antisecretory
    (H2- receptor
    antagonist)

    Indication

    Dose/
    Route And
    Frequency

    Used to
    50mg Q8
    prevent
    IVTT while
    ulcer while
    NPO
    patient is on
    NPO

    Mechanism Of
    Action

    Contraindication

    Competitiveinhi
    bition
    of histamine at
    H2-receptors of
    thegastric
    parietalcells,
    which
    inhibitsgastric
    acidsecretion,
    gastricvolume,
    andhydrogen
    ionconcentration
    arereduced.
    Does notaffect
    pepsinsecretion,
    pentagastrinstimulated
    intrinsicfactor
    secretion,
    or serum
    gastrin.

    Hypersensitivity
    toranitidine or
    anycomponent of
    theformulation.

    Side Effect

    Constipatio
    n
    Diarrhea
    Fatigue
    Headache
    Insomnia
    Muscle pain
    Nausea
    Vomiting
    Agitation
    Anemia
    Confusion
    Depression
    Easy
    bruisingor
    bleeding

    Nursing
    Responsibilities

    Assess patient for


    epigastric or
    abdominal pain
    and frank or occult
    blood in the stool,
    emesis, or
    gastric aspirate.
    Inform patient that
    it may cause
    drowsiness or
    dizziness.
    Inform patient that
    increased fluid and
    fiber intake may
    minimize
    constipation.
    Inform patient that
    medication may
    temporarily cause
    stools and tongue
    to appear gray b
    lack

    Drugs

    Classification Indication

    Antiprotozoal
    Diloxanide
    furoate

    The drug is
    used in
    intestinal
    amoebiasis
    and is given
    after any
    tissue
    amoebicide
    to eradicate
    cysts

    Dose/
    Route And
    Frequency

    PO 500mg
    3x a day for
    ten days

    Mechanism Of
    Action

    Contraindication

    Side Effect

    Luminal
    amebicide.
    {
    The
    mechanism of
    action of
    diloxanide is
    unknown. This
    agent destroys
    the
    trophozoites of
    E. histolytica
    that eventually
    form into cysts.
    The cysts are
    then excreted
    by persons
    infected with
    asymptomatic
    amebiasis.

    Hypersensitivity

    Flatulence,
    loss of
    appetite,
    nausea,
    vomiting,
    itching and
    hives

    Nursing
    Responsibilities

    You might also like